Access to medicine transforms lives.</br>Join us on a mission to reach 8 billion. | Access to Medicine

2026 AMR Benchmark

AMR doesn’t just threaten infection control. It undermines modern medicine.

Learn why AMR matters

News

Read the latest at the Foundation

Foundation's new report reveals opportunities for generic medicine manufacturers to bridge access gaps in Africa

2026 Index Methodology zeroes in on scalable actions capable of delivering lasting impact for more people

Briefing for the UN General Assembly 2026

How can governments steer pharmaceutical industry behaviour toward equitable access in the context of the UN High-Level Meeting?

Research hub

Explore our research reports and publications

Access to diabetes care for children and young people: Pharma companies' current actions and opportunities ahead

Featured Research

2024 Access to Medicine Index

19 November 2024

Patient centricity: How is the pharma industry addressing patient reach?

10 September 2024

Events and engagements

Sharing our insights to help drive change

Achieving equitable access to infectious diseases diagnostics: Learnings and pathways forward – Meeting Report

Steffi Van Uytfanghe to present insights on medical oxygen access gaps at 2026 Gasworld’s Global Industrial Gas Conference

02 December 2026

UBS and Neuberger Berman to co-host investor launch events for the tenth Access to Medicine Index

10 November 2026

Featured Conference

The Access to Medicine Foundation joins UN General Assembly 2026

22 September 2026

Access insights

Read our analyses of critical developments in the pharmaceutical industry

Turning momentum into vaccine manufacturing capacity in Africa

Commentary: Merck & Co. commits to broadening access to HIV prevention in LMICs

Commentary: MPP and Roche move to expand access to influenza treatment in LMICs